An "off-on" fluorescent sensor based on FRET and magnetic beads for APE1 activity detection in breast cancer cell lysates.
The activity of apurinic/apyrimidinic endonuclease 1 (APE1) is a key biomarker in breast cancer.
APA
Ren Z, Zhang Q, et al. (2026). An "off-on" fluorescent sensor based on FRET and magnetic beads for APE1 activity detection in breast cancer cell lysates.. Analytical methods : advancing methods and applications, 18(12), 2455-2463. https://doi.org/10.1039/d6ay00068a
MLA
Ren Z, et al.. "An "off-on" fluorescent sensor based on FRET and magnetic beads for APE1 activity detection in breast cancer cell lysates.." Analytical methods : advancing methods and applications, vol. 18, no. 12, 2026, pp. 2455-2463.
PMID
41800704
Abstract
The activity of apurinic/apyrimidinic endonuclease 1 (APE1) is a key biomarker in breast cancer. We report an "off-on" fluorescent nanosensor (OOFN) that combines fluorescence resonance energy transfer (FRET) with magnetic bead (MB) enrichment for simple and sensitive APE1 detection. The platform employs a MB-anchored FAM-labeled DNA strand (D1) hybridized with a BHQ1-labeled strand containing an AP site (D2). In the absence of APE1, close donor-acceptor proximity quenches fluorescence FRET. APE1 cleaves the AP site, releases the quencher, and restores fluorescence, while MBs enable easy separation to reduce background. The sensor achieves a detection limit of 0.03 U mL for purified APE1 and can detect activity from as few as 50 breast cancer cells. It reliably distinguishes APE1 levels between normal (MCF-10A) and cancerous (MCF-7, MDA-MB-231) cells, with >96% recovery in serum. This work provides a practical tool for activity-based APE1 detection in cancer research and diagnostics.
MeSH Terms
Humans; DNA-(Apurinic or Apyrimidinic Site) Lyase; Fluorescence Resonance Energy Transfer; Breast Neoplasms; Female; Cell Line, Tumor; MCF-7 Cells; Limit of Detection; Fluorescent Dyes; Biosensing Techniques
같은 제1저자의 인용 많은 논문 (5)
- K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy.
- The disguised liver abscess closely resembled diffuse hepatocellular carcinoma with portal vein tumor thrombus: a case description and literature analysis.
- Comparison of the safety and efficacy of different neoadjuvant therapy cycles for locally advanced gastric cancer: a retrospective propensity score-matched cohort study.
- Development of a self-assembling aggregation-induced emission nanoprobe for targeted therapy and real-time imaging in non-small cell lung cancer.
- Network pharmacology research integrating LC-MS/MS, machine learning, molecular docking, and dynamics simulation: key biomarkers and potential mechanisms of against prostate cancer.